TipRanks
Go Ultimate55% OFF

Top Gum (TPGM) AI Stock Analysis

IL:TPGM

Top Gum

(TASE:TPGM)

Select Model
Rating:37Underperform
Price Target:ILA 798.00â–¼(-6.49% Downside)
Action:reiterated
Date:10/30/26

The stock scores at the minimum due to unprofitability, negative free cash flow, and a persistent downtrend across all major moving averages with deeply oversold momentum. While revenue growth is strong, the lack of earnings and bearish technicals present significant risk, with no valuation or event-driven catalysts to offset these weaknesses.

Positive Factors
Revenue GrowthSustained revenue growth indicates that Top Gum continues expanding its sales base despite current profitability pressure. If the company can preserve demand while improving cost control and pricing, the larger revenue platform could support operating leverage and stronger earnings over the next several quarters.
Negative Factors
Persistent Net LossesThe shift from profits in 2021–2023 to deeply negative TTM net income is a material deterioration in earnings quality. A negative margin reduces retained capital, limits self-funded growth, and makes revenue expansion less valuable until the company demonstrates a durable return to profitability.

Top Gum (TPGM) vs. iShares MSCI Israel ETF (EIS)

-25%0%25%50%75%100%125%IL:TPGM-9.31%EIS+13.14%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
ILS 1.12B
Dividend Yield
―
Average Volume (3M)
77.47K
Price to Earnings (P/E)
-18.4
Beta (1Y)
0.48
Revenue Growth
58.86%
EPS Growth
-176.99%
Country
Israel
Employees
379
Sector
General
Sector Strength
55
Industry
Food Confectioners

Top Gum Business Overview & Revenue Model

Company Description

TopGum Industries Ltd. develops, manufactures, imports, sells, and markets dietary and nutritional supplement gummies. The company offers women’s health, beauty from within, active lifestyle, gut health, and immune support gummies. It also imports an...

Top Gum Financial Statement Overview

Summary

Strong revenue growth of 70% in 2025 and 26% TTM is offset by deep operating and net losses, negative ROE, and negative free cash flow despite positive operating cash flow. The company is in an aggressive, unprofitable growth phase with rising debt, resulting in a low financial health score.

Income Statement

35Negative

Balance Sheet

40Negative

Cash Flow

35Negative
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue126.67M100.95M59.27M45.60M43.91M33.07M
Gross Profit38.19M32.36M20.51M15.10M15.25M9.89M
EBITDA-8.34M-8.04M-2.61M6.27M6.23M4.49M
Net Income-17.94M-15.94M-6.49M3.21M3.63M1.58M
Balance Sheet
Total Assets246.59M206.00M108.20M104.84M63.68M59.57M
Cash, Cash Equivalents and Short-Term Investments15.08M32.83M10.14M12.11M4.33M17.93M
Total Debt83.47M51.26M31.20M25.06M7.99M2.40M
Total Liabilities111.73M115.10M45.62M37.26M17.41M12.13M
Stockholders Equity134.85M90.90M62.58M67.59M46.27M47.44M
Cash Flow
Free Cash Flow-9.06M-9.37M-6.70M-25.43M-12.18M-6.48M
Operating Cash Flow10.33M10.28M6.69M1.44M1.08M1.09M
Investing Cash Flow-37.53M-32.37M-12.99M-28.22M-13.40M-7.51M
Financing Cash Flow70.98M41.91M4.50M33.20M263.00K22.12M

Top Gum Technical Analysis

Technical Analysis SentimentNegative
Last Price853.40

Price Trends

50DMA994.30Negative
100DMA1136.48Negative
200DMA1344.15Negative

Market Momentum

MACD-34.53Positive
RSI26.95Positive
STOCH8.00Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:TPGM, the sentiment is Negative. The current price of 853.40 is below the 20-day moving average (MA) of 936.20, below the 50-day MA of 994.30, and below the 200-day MA of 1344.15, indicating a bearish trend. The MACD of -34.53 indicates Positive momentum. The RSI at 26.95 is Positive, neither overbought nor oversold. The STOCH value of 8.00 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IL:TPGM.

Top Gum Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

IL:TPGM against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
IL:WLFDIL:WLFD78OutperformILS 691.47M14.36――4.06%-21.69%
IL:ALBAIL:ALBA67NeutralILS 553.64M7.55―3.61%-1.02%42.98%
IL:GSFIIL:GSFI64NeutralILS 277.76M21.83―10.24%-22.23%-88.63%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
IL:TPGMIL:TPGM37UnderperformILS 1.12B-18.45――58.86%-176.99%

* General Sector Average

Performance Comparison

0%50%100%IL:TPGMIL:MEDNIL:GSFIIL:ALBAIL:WLFDIL:CRMLDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
IL:TPGM and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
IL:TPGMTop Gum Industries Ltd.853.40-90.50-9.59%
IL:MEDNMehadrin Ltd.28110.00-1130.00-3.86%
IL:GSFIGan Shmuel Foods Ltd1850.00-1064.00-36.51%
IL:ALBAAlbaad Massuot Yitzhak Ltd.2969.00352.0013.45%
IL:WLFDWilly Food Investments Ltd.5243.001332.0034.06%
IL:CRMLCarmel Corp Ltd1290.00-768.00-37.32%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 30, 2026